Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer. [electronic resource]
Producer: 20080915Description: 541-5 p. digitalISSN:- 0959-4973
- Adult
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Drug Resistance, Neoplasm
- Erythema -- chemically induced
- Female
- Foot
- Hand
- Humans
- Infusions, Intravenous
- Middle Aged
- Neoplasm Recurrence, Local
- Organoplatinum Compounds -- therapeutic use
- Ovarian Neoplasms -- drug therapy
- Paresthesia -- chemically induced
- Peritoneal Neoplasms -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.